Back
JetBlue Airways 10K Form
Sell
22
JBLU
JetBlue Airways
Last Price:
5.90
Seasonality Move:
3.35%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
2024-04-25 | 10Q | JBLU/JetBlue Airways Quarterly |
2023-10-31 | 10Q | JBLU/JetBlue Airways Quarterly |
2023-08-01 | 10Q | JBLU/JetBlue Airways Quarterly |
2023-04-28 | 10Q | JBLU/JetBlue Airways Quarterly |
2022-11-02 | 10Q | JBLU/JetBlue Airways Quarterly |
2022-08-05 | 10Q | JBLU/JetBlue Airways Quarterly |
Receive JBLU News And Ratings
See the #1 stock for the next 7 days that we like better than JBLU
JBLU Financial Statistics
Sales & Book Value
Annual Sales: | $9.62B |
---|---|
Cash Flow: | $-314M |
Price / Cash Flow: | 0 |
Annual Sales: | $7.62 |
Price / Book: | 0.77 |
Profitability
EPS (TTM): | -2.52000 |
---|---|
Net Income (TTM): | $-854M |
Gross Margin: | $1.78B |
Return on Equity: | -28.99% |
Return on Assets: | -5.96% |
JetBlue Airways Earnings Forecast
Key JetBlue Airways Financial Ratios
- The Gross Profit Margin over the past 21 years for JBLU is 18.53%.
- The Selling, General & Administrative Expenses for JBLU have been equal to 3.29% of Gross Profit Margin.
- The Research & Development expenses have been 0.00% of Revenue.
- The Interest Expense is -67.74% of Operating Income.
- The Net Earning history of JBLU is -3.22% of Total Revenues.
- Per Share Earnings over the last 25 years have been positive in 17 years.
JetBlue Airways Stock Price Chart
Industry, Sector and Symbol
Stock Exchange: | NASDAQ |
---|---|
Industry: | Passenger Airlines |
Sector: | Industrials |
Current Symbol: | JBLU |
CUSIP: | 477143 |
Website: | jetblue.com |
Debt
Debt-to-Equity Ratio: | 3.11 |
---|---|
Current Ratio: | 1.21 |
Quick Ratio: | 1.14 |
Price-to-Earnings
Trailing P/E Ratio: | 0 |
---|---|
Forward P/E Ratio: | 0 |
JBLU Technical Analysis vs Fundamental Analysis
Sell
22
JetBlue Airways (JBLU)
is a Sell
Is JetBlue Airways a Buy or a Sell?
-
JetBlue Airways stock is rated a Sell
The current JetBlue Airways [JBLU] share price is $5.90. The Score for JBLU is 22, which is 56% below its historic median score of 50, and infers higher risk than normal.